Graupel Pharma Private Limited - Company Profile

It is a chemicals private limited company based in Hyderabad, Telangana, India, established in 2011.
2011 Hyderabad, Telangana, India Active
Last Updated:
Access Report
About Graupel Pharma Private Limited

Graupel Pharma Private Limited, a active private limited company, was established on 07 October 2011 in Hyderabad, Telangana, India. Engaging in manufacturing within the chemicals sector, it holds CIN: U24100TG2011PTC076865. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹5.00 M and a paid-up capital of ₹1.00 M.

It upholds a active non-compliant status. Its leadership includes Donikena Purnasri (Additional Director), Sridhar Donekana (Additional Director). Past directors included Donikena Sridhar, Donikena Purnasri, Purushotham Namala. It holds ₹1.00 Cr open charges and no settled loans. It is based at H.No.1-4-62/1C, Sneha Nagar Street No.8, Habsiguda, Hyderabad, Telangana, 500020.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24100TG2011PTC076865

  • Registration Number

    076865

  • Incorporation Date

    07 October 2011

  • Authorized Capital

    ₹5.00 M

  • Paid-Up Capital

    ₹1.00 M

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 5.00 M
  • Paid Up Capital ₹ 1.00 M
  • Company Age 14 Year, 7 Months
  • Open Charges ₹ 1.00 Cr
Company report

Graupel Pharma Private Limited

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Graupel Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Graupel Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Donikena Purnasri Additional Director 16 Mar 2015 Current
Sridhar Donekana Additional Director 05 Oct 2012 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 12 Mar 2012 Past
Pramod Abcsdd Managing Director 12 Oct 2012 Past
Pramod Abcsdd Additional Director 03 Jul 2012 Past
Pramod Abcsdd Additional Director 23 Mar 2015 Past
Pramod Abcsdd Director 03 Apr 2012 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Graupel Pharma.

Enhance accessibility to Graupel Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Graupel Pharma revenue growth over time
Graupel Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Graupel Pharma?

Unlock access to Graupel Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹10,000,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • Bank Of India : 1.00 Cr
Latest Charge Details
Date Lender Amount Status
17 Dec 2012 Bank Of India ₹1.00 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Graupel Pharma?

Unlock and access historical data on people associated with Graupel Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Graupel Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Graupel Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Graupel Pharma
Recent Activity within the Organization
  • Director Appointment

    The activity Donikena Purnasri was appointed as a Additional Director was appointed as a Additional Director on 16 Mar 2015 & has been associated with this company since 11 years 1 month . was completed.

  • Charges

    The activity A charge with Bank Of India amounted to Rs. 10.00 M with Charge ID 10397212 was registered on 17 Dec 2012. was completed.

  • Director Appointment

    Sridhar Donekana was appointed as a Additional Director was appointed as a Additional Director on 05 Oct 2012 & has been associated with this company since 13 years 7 months . was recorded as a recent event.

  • Company Incorporation

    The activity Graupel Pharma Private Limited was registered on 07 Oct 2011 with Roc Hyderabad & aged 14 years 7 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Graupel Pharma Private Limited?

The CIN of Graupel Pharma Private Limited is U24100TG2011PTC076865.

Where is Graupel Pharma Private Limited headquartered?

Graupel Pharma Private Limited is headquartered at H.No.1-4-62/1C, Sneha Nagar Street No.8, Habsiguda, Hyderabad, Telangana, 500020.

When was Graupel Pharma Private Limited incorporated?

Graupel Pharma Private Limited was incorporated on 07 October 2011.

Who are the current directors of Graupel Pharma Private Limited?

The current directors of Graupel Pharma Private Limited are

What is the primary industry of Graupel Pharma Private Limited?

The primary industry of Graupel Pharma Private Limited is Chemicals.

Is Graupel Pharma Private Limited a listed company?

Graupel Pharma Private Limited is unlisted.

What is the capital structure of Graupel Pharma Private Limited?

The authorized capital of Graupel Pharma Private Limited is ₹5.00 M, and the paid-up capital is ₹1.00 M.

What is the compliance status of Graupel Pharma Private Limited?

The compliance status of Graupel Pharma Private Limited is Active Non-Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available